In response to the COVID-19 pandemic, Force Therapeutics, LLC has announced the launch of its Force Intelligent Care Plan™, a new platform to scale individualized remote patient care.
Force Therapeutics Launches Force Intelligent Care Plan
1 min read Premium comments
Secondary#covid19#forcetherapeutics#intelligentcareplan
During the COVID-19 pandemic, the need for virtual healthcare solutions has grown. The cancellation of elective surgeries and stay-at-home orders has only increased the need for patients to communicate with their physicians remotely. Patients continue to need physical therapy and guided instruction on treatment and recovery.
Founded in 2010, New York-based Force Therapeutics provides web and mobile applications to assist with patient rehabilitation. Its platform features include virtual rehab, digital navigation, PRO collection, data, analytics, smart tasks, and American Joint Replacement Registry integration.
Since its founding, Force Therapeutics has worked with more than 70 major hospital systems and gathered more than 4 million data points. It has used this data to educate clinicians and administrators on methods for care redesign.
This data has enabled Force Therapeutics to launch Force Intelligent Care Plan. With Force Intelligent Care Plan providers can scale individualized preoperative and postoperative care. The platform adapts to the risk factors, specific needs, and treatment of each patient.
Force Therapeutics Product Manager of Provider Experience Ange Delgado commented on the platform’s configuration. Delgado said, “This technology is the future of clinical artificial intelligence.”
Delgado continued, “Starting with the millions of data points that we’ve collected over the last decade, coupled with continued collection of patient reported outcomes, this technology will disrupt the way providers deliver virtual care.”
Patient treatment and recovery is changing and technology is adapting to make it more accessible in every situation. This new platform promises to deliver personalized patient care to increase accessibility and improve recovery.
Force Therapeutics Founder and CEO Bronwyn Spira commented, “Our comprehensive software is delivering incredible value to patients and providers.”
Spira continued, “This is the next generation of clinical intelligence; providers working with technology to deliver the best possible care to every patient.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.